首页> 外文期刊>International heart journal >Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis A Case Report
【24h】

Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis A Case Report

机译:药物涂层球囊冠状动脉血管成形术后晚期支架血栓形成,用于支架再狭窄的案例报告

获取原文
       

摘要

A 41-year-old woman with chest pain for 6 hours was admitted to our chest pain center, presenting with acute myocardial infarction. Coronary angiography showed acute total occlusion in the proximal left anterior descending artery due to late stent thrombosis. After thrombus aspiration and intracoronary administration of 0.5 mg tirofiban, repeated angiography showed that no obvious residual stenosis remained. The patient underwent drug-coated balloon angioplasty 69 days ago and was then administered dual antiplatelet treatment (aspirin and clopidogrel) uninterruptedly. Genetic testing found that both cytochrome P450 2C19 (CYP2C19) (G681A) and glycoprotein Ia (GPIa) (C807T, G873A) were hybrid mutant types, demonstrating that the patient was possibly resistant to clopidogrel and aspirin simultaneously. Thus, clopidogrel was replaced by ticagrelor and no more cardiovascular adverse events occurred during the 2-year follow-up.
机译:一个41岁的女性,胸痛6个小时患者进入我们的胸痛中心,呈现出急性心肌梗死。 由于晚期支架血栓形成,冠状动脉造影显示近端左前期下降动脉的急性全闭塞。 在血栓吸入和颅内施用0.5mg替洛菲班后,重复血管造影显示,仍然没有明显的残余狭窄。 患者在69天前接受了药物涂层的球囊血管成形术,然后不间断地施用双抗血小板治疗(阿司匹林和氯吡格雷)。 遗传测试发现细胞色素P450 2C19(CYP2C19)(G681A)和糖蛋白IA(GPIA)(GPIA)(C807T,G873A)是杂化突变体类型,证明患者可能同时抵抗氯吡格雷和阿司匹林。 因此,氯吡格雷被TiCagreloLor取代,在2年的随访期间没有发生的心血管不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号